Atrás
Rango del Día
$15.49
$15.82
Rango de 52 Semanas
$10.45
$18.92
Volumen
490,370
Promedio 50D / 200D
$17.19
/
$15.41
Cierre Anterior
$15.84
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -15.5 | 0.3 |
| P/B | 0.9 | 2.9 |
| ROE % | -5.6 | 3.7 |
| Net Margin % | -7.1 | 3.8 |
| Rev Growth 5Y % | 7.9 | 10.0 |
| D/E | 0.8 | 0.2 |
Precio Objetivo de Analistas
Hold
$18.90
+20.3%
Low: $16.00
High: $21.00
P/E Futuro
20.5
EPS Futuro
$0.77
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
5.4 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$1.78
$1.76 – $1.79
|
5.9 B | 1 |
| FY2028 |
$1.35
$1.04 – $1.58
|
6.1 B | 3 |
| FY2027 |
$1.05
$0.94 – $1.26
|
5.7 B | 8 |
Puntos Clave
Revenue grew 7.89% annually over 5 years — modest growth
Negative free cash flow of -66.00M
Capital efficient — spends only 6.84% of revenue on capex
ROIC of 1.01% — low return on invested capital
Interest coverage of 0.37× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
7.89%
Revenue (1Y)6.47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-5.57%
ROIC1.01%
Net Margin-7.06%
Op. Margin3.12%
Seguridad
Debt / Equity
0.83
Current Ratio1.55
Interest Coverage0.37
Valoración
P/E Ratio
-15.46
P/B Ratio0.86
EV/EBITDA66.37
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.47% | Revenue Growth (3Y) | 10.92% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5.10B | Net Income (TTM) | -360.00M |
| ROE | -5.57% | ROA | -2.57% |
| Gross Margin | 58.71% | Operating Margin | 3.12% |
| Net Margin | -7.06% | Free Cash Flow (TTM) | -66.00M |
| ROIC | 1.01% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.83 | Current Ratio | 1.55 |
| Interest Coverage | 0.37 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -15.46 | P/B Ratio | 0.86 |
| P/S Ratio | 1.09 | PEG Ratio | -1.26 |
| EV/EBITDA | 66.37 | Dividend Yield | 0.00% |
| Market Cap | 5.57B | Enterprise Value | 10.55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.10B | 4.79B | 4.15B | 3.77B | 3.77B |
| Net Income | -360.00M | -317.00M | -260.00M | 6.00M | 182.00M |
| EPS (Diluted) | -1.02 | -0.90 | -0.74 | 0.04 | 0.52 |
| Gross Profit | 3.00B | 2.92B | 2.50B | 2.25B | 2.30B |
| Operating Income | 159.00M | 162.00M | 130.00M | 207.00M | 329.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 14.02B | 13.47B | 13.44B | 11.14B | 10.82B |
| Total Liabilities | 7.50B | 6.93B | 6.52B | 4.04B | 1.42B |
| Shareholders' Equity | 6.45B | 6.47B | 6.85B | 7.03B | 9.33B |
| Total Debt | 5.37B | 4.94B | 4.68B | 2.55B | 140.00M |
| Cash & Equivalents | 383.00M | 305.00M | 334.00M | 380.00M | 174.00M |
| Current Assets | 2.98B | 2.79B | 2.74B | 2.14B | 1.64B |
| Current Liabilities | 1.92B | 1.74B | 1.58B | 1.30B | 1.10B |